Annual report pursuant to Section 13 and 15(d)

Statements of Shareholders' Equity (Deficit)

v3.20.1
Statements of Shareholders' Equity (Deficit) - USD ($)
Series C Preferred Stock [Member]
Series D Preferred Stock [Member]
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2017 $ 368 $ 1,711,197 $ (11,460,989) $ (9,749,424)
Balance, shares at Dec. 31, 2017 3,679,500      
Stock based compensation expense $ 1 557,041 557,042
Stock based compensation expense, shares 8,334      
Stock issued in settlement of litigation 939,538 939,538
Stock issued in settlement of litigation, shares      
Conversion of Class B convertible preferred stock $ 137 4,961,431 4,961,568
Conversion of Class B convertible preferred stock, shares 1,366,768      
Issuance of warrants to third parties for capital raise 594,293 594,293
Conversion of deferred salaries $ 14 650,086 650,100
Conversion of deferred salaries, shares 136,863      
Conversion of convertible debentures $ 172 6,267,924 6,268,096
Conversion of convertible debentures, shares 1,726,678      
Conversion of advance from officer $ 4 199,996 200,000
Conversion of advance from officer, shares 42,105      
Conversion of notes payable $ 22 782,728 782,750
Conversion of notes payable, shares 215,625      
Sale of common stock in public offering $ 267 8,013,961 8,014,228
Sale of common stock in public offering, shares 2,670,000      
Sale of common stock in over-allotment to underwriters $ 2 121,907 121,909
Sale of common stock in over-allotment to underwriters, shares 25,000      
Common stock deemed dividend (980,375) (980,375)
Common stock deemed dividend, shares      
Accretion of redeemable convertible preferred stock dividend (3,667,620) (3,667,620)
Accretion of redeemable convertible preferred stock dividend, shares      
Net loss (27,651,412) (27,651,412)
Balance at Dec. 31, 2018 $ 987 20,152,107 (39,112,401) (18,959,307)
Balance, shares at Dec. 31, 2018 9,870,873      
Stock based compensation expense 336,637 336,637
Accretion of redeemable convertible preferred stock dividend          
Issuance of common stock upon exercise of Series A Warrants, net of cost $ 42 2,172,638 2,172,680
Issuance of common stock upon exercise of Series A Warrants, net of cost, shares 424,116      
Issuance of common stock as inducement to exercise Series A Warrants $ 51 (51)
Issuance of common stock as inducement to exercise Series A Warrants, shares 508,940      
Issuance of common stock upon exercise of Placement Agent Warrants 16,818 16,818
Issuance of common stock upon exercise of Placement Agent Warrants, shares 4,004      
Issuance of Series C preferred stock upon exchange of Series A and Series B warrants 3,671,024 3,671,024
Issuance of Series C preferred stock upon exchange of Series A and Series B warrants, shares      
Issuance of common stock upon exercise of Series B warrants $ 1,620 14,582,751 14,584,371
Issuance of common stock upon exercise of Series B warrants, shares 4,268 16,192,218      
Issuance of common stock upon Series C preferred (conversion) $ 300 (300)
Issuance of common stock upon Series C preferred (conversion), shares (3,000) 3,000,000      
Warrants issued in connection with convertible notes payable 595,000 595,000
Issuance of common stock upon conversion of convertible note payable $ 300 293,454 293,754
Issuance of common stock upon conversion of convertible note payable, shares 3,000,000      
Issuance of Series D preferred stock upon exchange of convertible note payable $ 4,816,485 4,816,485
Issuance of Series D preferred stock upon exchange of convertible note payable, shares 5,775      
Net loss (4,300,969) (4,300,969)
Balance at Dec. 31, 2019 $ 5,775,000 $ 3,300 $ 41,820,078 $ (43,413,370) $ 3,226,493
Balance, shares at Dec. 31, 2019 1,268 5,775 33,000,151